Several studies have demonstrated that TAOK1 possesses oncogenic properties in non-small cell lung cancer (NSCLC), hepatocellular carcinoma (HCC), and ESCC [7,8,9]. This evidence concerns the gene TAOK1 and hepatocellular carcinoma.